Overview
Trail-resistant breast carcinoma is a type of breast cancer that is resistant to treatments that involve TNF-related apoptosis-inducing ligand (TRAIL). This form of cancer is diagnosed when cells are no longer affected by TRAIL-mediated apoptosis, which is a form of cell death. Its significance is that it suggests a decreased response to chemotherapy or other treatments for patients with this form of cancer. Additionally, it can be used as a biomarker to predict the overall prognosis of the cancer. It may also be used to identify more effective treatments and determine the origin of the cancer cells.
Research published in this journal
No peer-reviewed research on this exact topic has been published in Breast Cancer Survival yet. Browse the journal →